ClinicalTrials.gov
ClinicalTrials.gov Menu

Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00253422
Recruitment Status : Unknown
Verified May 2011 by National Cancer Institute (NCI).
Recruitment status was:  Active, not recruiting
First Posted : November 15, 2005
Last Update Posted : May 17, 2011
Sponsor:
Information provided by:
National Cancer Institute (NCI)